Atrovent vs Wixela
What to choose Atrovent or Wixela
Atrovent is inhaler of type Rescue while Wixela is of Control type. Atrovent and Wixela are both brand inhalers. Atrovent is manufactured by pharmaceutical company Boehringer Ingelheim, while Wixela is manufactured by Viatris. The main substance of Atrovent is Ipratropium. The available dosage for Atrovent is 21 mcg. The main substances of Wixela are Fluticasone and Salmeterol. The available dosage for Wixela is 250/50.
The average cost for Atrovent is approximately $365 while current cost for Wixela is around $240, said Bruce Brown, an Associate Professor at the University of Wisconsin-Platteville and a Medical Director at a clinic that uses Atrovent and Wixela.
Atrovent and Wixela Comparison
| Atrovent | Wixela | |
|---|---|---|
| Type: | Rescue | Control |
| Manufacturer: | Boehringer Ingelheim | Viatris |
| Substance: | Ipratropium | Fluticasone + Salmeterol |
| Dosage: | 21 mcg | 250/50 |
| Avg Price: | $365 | $240 |